How to Leverage the Medicare Program for a COVID-19 Vaccination Campaign

JAMA. 2021 Jan 5;325(1):21-22. doi: 10.1001/jama.2020.22720.

Authors

Nicole Lurie¹, Bettina Experton²

Affiliations

¹ Coalition for Epidemic Preparedness Innovations (CEPI), Harvard Medical School, Boston, Massachusetts.
² Humetrix, Del Mar, California.

PMID: 33211081
DOI: 10.1001/jama.2020.22720

No abstract available

MeSH terms

COVID-19 / epidemiology
COVID-19 / prevention & control*
COVID-19 Vaccines / supply & distribution
Centers for Medicare and Medicaid Services, U.S.
Data Accuracy
Humans
Immunization Programs / organization & administration*
Influenza A Virus, H1N1 Subtype
Influenza Vaccines / administration & dosage
Influenza, Human / epidemiology
Influenza, Human / prevention & control
Insurance Claim Review / standards
Medicare / statistics & numerical data*
Models, Statistical
SARS-CoV-2*
United States / epidemiology

Substances

COVID-19 Vaccines
Influenza Vaccines